Close Menu

stock listing

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Rosetta Genomics disclosed it has been warned by the Nasdaq that it is not in compliance with a listing requirement.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – A Nasdaq panel has granted Pressure BioSciences' request for continued listing on the exchange, the company said today.

The company still needs to comply with the Nasdaq's minimum $1 bid price requirement.

Separately, Nasdaq said that Rosetta must regain compliance with the minimum $1.00 bid price requirement for continued listing on Nasdaq by Aug. 8, 2011, for a minimum of 10 consecutive business days.

CombiMatrix had voluntarily applied for the transfer rather than submit a plan to the exchange to regain compliance with Nasdaq Global Market listing requirements.

The firm also reported total shareholders' equity of approximately $4.9 million, which satisfies Amex's listing requirement of $4 million.

The company's stock began trading on the Nasdaq this morning. It had traded on the Pink Sheets since being delisted in 2008.


University of Idaho researchers model the scientific discovery process to examine the link between reproducibility and scientific truth.

A bill passed by a US House of Representatives appropriations subcommittee would give scientific agencies including the National Science Foundation boosts in funding.

Relocating USDA agencies outside of Washington, DC, may make them less effective, critics of the move tell NPR.

In PLOS this week: genes that help Borrelia burgdorferi survive in ticks, CiliaCarta collection of about 1,000 suspected cilia genes, and more.